Published in Am J Psychiatry on May 01, 1993
Validity of the prodromal risk syndrome for first psychosis: findings from the North American Prodrome Longitudinal Study. Schizophr Bull (2009) 2.90
Psychiatric comorbidities and schizophrenia. Schizophr Bull (2008) 2.69
How prevalent are anxiety disorders in schizophrenia? A meta-analysis and critical review on a significant association. Schizophr Bull (2009) 1.69
Substance use in clinical high risk for psychosis: a review of the literature. Early Interv Psychiatry (2013) 1.06
Substance use and cognition in early psychosis. J Psychiatry Neurosci (2003) 0.98
Substance abuse in first-episode schizophrenic patients: a retrospective study. Clin Pract Epidemiol Ment Health (2006) 0.98
Are cannabis use disorders associated with an earlier age at onset of psychosis? A study in first episode schizophrenia. Schizophr Res (2010) 0.85
Using internet enabled mobile devices and social networking technologies to promote exercise as an intervention for young first episode psychosis patients. BMC Psychiatry (2011) 0.84
Moderated online social therapy for carers of young people recovering from first-episode psychosis: study protocol for a randomised controlled trial. Trials (2017) 0.76
Prevalence of comorbid anxiety disorders in schizophrenia. Ind Psychiatry J (2017) 0.75
Gender differences in psychotic disorders with concurrent substance use. J Dual Diagn (2014) 0.75
Prevalence of Substance Use in Patients Diagnosed with Schizophrenia. Noro Psikiyatr Ars (2016) 0.75
One hundred years of schizophrenia: a meta-analysis of the outcome literature. Am J Psychiatry (1994) 5.29
Clinical and research implications of the diagnosis of dysphoric or mixed mania or hypomania. Am J Psychiatry (1992) 2.70
Childhood abuse in first-episode psychosis. Br J Psychiatry (1994) 2.17
A novel augmentation strategy for treating resistant major depression. Am J Psychiatry (2001) 2.05
Lower left temporal lobe MRI volumes in patients with first-episode schizophrenia compared with psychotic patients with first-episode affective disorder and normal subjects. Am J Psychiatry (1998) 2.00
A double-blind, randomized comparison of the efficacy and safety of intramuscular injections of olanzapine, lorazepam, or placebo in treating acutely agitated patients diagnosed with bipolar mania. J Clin Psychopharmacol (2001) 1.86
Extent of comorbidity between mental state and personality disorders. J Pers Disord (1997) 1.81
Structural insights into the stereochemistry of the cyclooxygenase reaction. Nature (2000) 1.79
Bipolar spectrum disorders in patients diagnosed with velo-cardio-facial syndrome: does a hemizygous deletion of chromosome 22q11 result in bipolar affective disorder? Am J Psychiatry (1996) 1.71
Two-year syndromal and functional recovery in 219 cases of first-episode major affective disorder with psychotic features. Am J Psychiatry (2000) 1.66
Arachidonic acid oxygenation by COX-1 and COX-2. Mechanisms of catalysis and inhibition. J Biol Chem (1999) 1.64
Mood stabilizer combinations: a review of safety and efficacy. Am J Psychiatry (1998) 1.57
Unipolar mania reconsidered: evidence from an elderly cohort. Br J Psychiatry (1994) 1.57
Predominant recurrence polarity among 928 adult international bipolar I disorder patients. Acta Psychiatr Scand (2011) 1.52
The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. I. Study rationale and design. Schizophr Res (2003) 1.47
Substance abuse and the chronically mentally ill: a description of dual diagnosis treatment services in a psychiatric hospital. Community Ment Health J (1995) 1.45
The adverse effect profile and efficacy of divalproex sodium compared with valproic acid: a pharmacoepidemiology study. J Clin Psychiatry (1999) 1.45
First-episode schizophreniform disorder: comparisons with first-episode schizophrenia. Schizophr Res (2000) 1.44
Increasing frequency of the diagnosis of obsessive-compulsive disorder. Am J Psychiatry (1992) 1.43
Omega-3 fatty acids--the missing link? Arch Gen Psychiatry (1999) 1.41
First-episode schizophrenic psychosis differs from first-episode affective psychosis and controls in P300 amplitude over left temporal lobe. Arch Gen Psychiatry (1998) 1.40
Shifts in diagnostic frequencies of schizophrenia and major affective disorders at six North American psychiatric hospitals, 1972-1988. Am J Psychiatry (1993) 1.40
The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. II. Baseline characteristics of the "prodromal" sample. Schizophr Res (2003) 1.29
Spatial requirements for 15-(R)-hydroxy-5Z,8Z,11Z, 13E-eicosatetraenoic acid synthesis within the cyclooxygenase active site of murine COX-2. Why acetylated COX-1 does not synthesize 15-(R)-hete. J Biol Chem (2000) 1.29
The McLean-Harvard first-episode project: 6-month symptomatic and functional outcome in affective and nonaffective psychosis. Biol Psychiatry (2000) 1.28
MRI study of cavum septi pellucidi in schizophrenia, affective disorder, and schizotypal personality disorder. Am J Psychiatry (1998) 1.28
Form of DNA and the nature of interactions with proteins in chromatin. Nucleic Acids Res (1978) 1.26
Effects of the rate of discontinuing lithium maintenance treatment in bipolar disorders. J Clin Psychiatry (1996) 1.23
Medication compliance among patients with bipolar disorder and substance use disorder. J Clin Psychiatry (1998) 1.20
Choline, myo-inositol and mood in bipolar disorder: a proton magnetic resonance spectroscopic imaging study of the anterior cingulate cortex. Bipolar Disord (2000) 1.18
Clinical risk following abrupt and gradual withdrawal of maintenance neuroleptic treatment. Arch Gen Psychiatry (1997) 1.18
Olanzapine versus haloperidol treatment in first-episode psychosis. Am J Psychiatry (1999) 1.16
Clozapine in the treatment of refractory psychotic mania. Am J Psychiatry (2000) 1.15
Lithium treatment and risk of suicidal behavior in bipolar disorder patients. J Clin Psychiatry (1998) 1.12
The effects of race and comorbidity on clinical diagnosis in patients with psychosis. J Clin Psychiatry (1993) 1.10
The deficit syndrome in the DSM-IV Field Trial: I. Alcohol and other drug abuse. Schizophr Res (1996) 1.10
Molecular analysis of velo-cardio-facial syndrome patients with psychiatric disorders. Am J Hum Genet (1997) 1.08
A prospective open-label treatment trial of olanzapine monotherapy in children and adolescents with bipolar disorder. J Child Adolesc Psychopharmacol (2001) 1.08
Symptoms and functioning of patients with bipolar disorder six months after hospitalization. Hosp Community Psychiatry (1988) 1.05
Conformational transitions in oriented fibres of the synthetic polynucleotide poly[d(AT)].poly[d(AT)] double helix. Nature (1983) 1.04
Functional impairment and cognition in bipolar disorder. Psychiatr Q (2000) 1.04
Heuristic models of comorbidity of axis I and axis II disorders. J Pers Disord (1997) 1.03
Ultra-ultra rapid cycling bipolar disorder is associated with the low activity catecholamine-O-methyltransferase allele. Mol Psychiatry (1998) 1.03
Risk of recurrence following discontinuation of lithium treatment in bipolar disorder. Arch Gen Psychiatry (1991) 1.02
Structural brain abnormalities in first-episode mania. Biol Psychiatry (1993) 1.02
A double-blind trial of bupropion versus desipramine for bipolar depression. J Clin Psychiatry (1994) 1.01
Summer birth and the deficit syndrome of schizophrenia. Am J Psychiatry (1998) 1.01
Medication prescribing patterns for patients with bipolar I disorder in hospital settings: adherence to published practice guidelines. Bipolar Disord (2001) 1.01
Staging systems in bipolar disorder: an International Society for Bipolar Disorders Task Force Report. Acta Psychiatr Scand (2014) 0.99
Basal ganglia choline levels in depression and response to fluoxetine treatment: an in vivo proton magnetic resonance spectroscopy study. Biol Psychiatry (1997) 0.99
Binding of quinoline analogues of echinomycin to deoxyribonucleic acid. Role of the chromophores. Biochem J (1980) 0.99
Racial differences in the diagnosis of psychosis. Schizophr Res (1996) 0.99
Clozapine therapy in refractory affective disorders: polarity predicts response in long-term follow-up. J Clin Psychiatry (1994) 0.98
Decreased brain choline uptake in older adults. An in vivo proton magnetic resonance spectroscopy study. JAMA (1995) 0.97
Functional impairment in patients with mania: baseline results of the EMBLEM study. Bipolar Disord (2007) 0.96
Antidepressant-associated mania: a controlled comparison with spontaneous mania. Am J Psychiatry (1994) 0.96
DSM-5 mixed specifier for manic episodes: evaluating the effect of depressive features on severity and treatment outcome using asenapine clinical trial data. J Affect Disord (2013) 0.96
Maintenance treatment in bipolar disorder. Arch Gen Psychiatry (2000) 0.95
The deficit syndrome in the DSM-IV Field Trial. Part II. Depressive episodes and persecutory beliefs. Schizophr Res (1996) 0.95
Alterations in parathyroid dynamics in lithium-treated subjects. J Clin Endocrinol Metab (1997) 0.95
Telephone versus in-person clinical and health status assessment interviews in patients with bipolar disorder. Harv Rev Psychiatry (1998) 0.94
Omega-3 fatty acids, homocysteine, and the increased risk of cardiovascular mortality in major depressive disorder. Harv Rev Psychiatry (2001) 0.93
Clozapine in severe mood disorders. J Clin Psychiatry (1995) 0.93
The McLean First-Episode Psychosis Project: six-month recovery and recurrence outcome. Schizophr Bull (1992) 0.93
Predicting the course and outcome of bipolar disorder: a review. Eur Psychiatry (2010) 0.92
Outcome after rapid vs gradual discontinuation of lithium treatment in bipolar disorders. Arch Gen Psychiatry (1993) 0.92
Onset-age of bipolar disorders at six international sites. J Affect Disord (2009) 0.92
Lack of insight in bipolar disorder. The acute manic episode. J Nerv Ment Dis (1995) 0.91
Episode cycles with increasing recurrences in first-episode bipolar-I disorder patients. J Affect Disord (2011) 0.90
Open trial of S-adenosylmethionine for treatment of depression. Am J Psychiatry (1984) 0.89
Prevalence and characteristics of physical and sexual abuse among psychiatric outpatients. Psychiatr Serv (1996) 0.89
Inhibitory effects of omega-3 fatty acids on protein kinase C activity in vitro. Mol Psychiatry (2001) 0.89
Stigma and functioning in patients with bipolar disorder. J Affect Disord (2010) 0.89
Comparison of objective and subjective assessments of sleep time in subjects with bipolar disorder. J Affect Disord (2013) 0.89
Pre- and perinatal complications and risk for bipolar disorder: a retrospective study. J Affect Disord (1998) 0.89
Transfer of psychiatric inpatients to a general hospital due to adverse drug reactions. Psychosomatics (1997) 0.88
The Tridimensional Personality Questionnaire as a predictor of six-month outcome in first episode mania. Psychiatry Res (1993) 0.88
Four cases of obstructive sleep apnea associated with treatment-resistant mania. J Clin Psychiatry (1991) 0.88
EEG abnormalities before clozapine therapy predict a good clinical response to clozapine. Ann Clin Psychiatry (1996) 0.87
Scale matters: the need for a Bipolar Depression Rating Scale (BDRS). Acta Psychiatr Scand Suppl (2004) 0.86
Nucleosome structure: sites of interaction of proteins in the DNA grooves as determined by Raman scattering. Biochemistry (1979) 0.86
Comorbidity in mania at first hospitalization. Am J Psychiatry (1992) 0.86